119 related articles for article (PubMed ID: 32972109)
1. Downregulation of USP33 inhibits Slit/Robo signaling pathway and is associated with poor patient survival of glioma.
Han PP; Zhang GQ; Li L; Yue L
J Neurosurg Sci; 2023 Feb; 67(1):113-120. PubMed ID: 32972109
[TBL] [Abstract][Full Text] [Related]
2. USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.
Huang Z; Wen P; Kong R; Cheng H; Zhang B; Quan C; Bian Z; Chen M; Zhang Z; Chen X; Du X; Liu J; Zhu L; Fushimi K; Hua D; Wu JY
Int J Cancer; 2015 Apr; 136(8):1792-802. PubMed ID: 25242263
[TBL] [Abstract][Full Text] [Related]
3. Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT.
Xia Y; Wang L; Xu Z; Kong R; Wang F; Yin K; Xu J; Li B; He Z; Wang L; Xu H; Zhang D; Yang L; Wu JY; Xu Z
Cell Prolif; 2019 May; 52(3):e12606. PubMed ID: 30896071
[TBL] [Abstract][Full Text] [Related]
4. USP33, a new player in lung cancer, mediates Slit-Robo signaling.
Wen P; Kong R; Liu J; Zhu L; Chen X; Li X; Nie Y; Wu K; Wu JY
Protein Cell; 2014 Sep; 5(9):704-13. PubMed ID: 24981056
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.
Yuasa-Kawada J; Kinoshita-Kawada M; Rao Y; Wu JY
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14530-5. PubMed ID: 19706539
[TBL] [Abstract][Full Text] [Related]
6. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.
Liu H; Zhang Q; Li K; Gong Z; Liu Z; Xu Y; Swaney MH; Xiao K; Chen Y
Oncotarget; 2016 Dec; 7(49):81223-81240. PubMed ID: 27835898
[TBL] [Abstract][Full Text] [Related]
8. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
Chen Y; Pang X; Ji L; Sun Y; Ji Y
Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
[TBL] [Abstract][Full Text] [Related]
9. [USP33 suppresses lung adenocarcinoma lung cell invasion and metastasis by down-regulating SLIT2/ROBO1 signaling pathway].
Wang Y; Zhang S; Mu S; Zhang B; Ma S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):956-961. PubMed ID: 30187867
[TBL] [Abstract][Full Text] [Related]
10. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway.
Liu X; Xu J; Shen B; Xu J; Jiang J
Cell Death Dis; 2023 Jun; 14(6):362. PubMed ID: 37322017
[TBL] [Abstract][Full Text] [Related]
11. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma.
Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G
Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698
[TBL] [Abstract][Full Text] [Related]
12. Midline crossing and Slit responsiveness of commissural axons require USP33.
Yuasa-Kawada J; Kinoshita-Kawada M; Wu G; Rao Y; Wu JY
Nat Neurosci; 2009 Sep; 12(9):1087-9. PubMed ID: 19684588
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
14. USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.
Zhang A; Huang Z; Tao W; Zhai K; Wu Q; Rich JN; Zhou W; Bao S
EMBO J; 2022 Apr; 41(7):e109187. PubMed ID: 35191554
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
[TBL] [Abstract][Full Text] [Related]
16. USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC-3 and SW1990 cells.
Zhong B; Zhu Q; Wang L; Wang F; Zheng Y; Lin S; Cheng X
Cell Biol Int; 2023 Aug; 47(8):1368-1380. PubMed ID: 37076992
[TBL] [Abstract][Full Text] [Related]
17. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
20. Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.
Chan NC; den Besten W; Sweredoski MJ; Hess S; Deshaies RJ; Chan DC
J Biol Chem; 2014 Jul; 289(28):19789-98. PubMed ID: 24855649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
